Posted on May 18, 2022

By Arif Dalvi, MD, MBAPalm Beach Neuroscience Institute By definition essential tremor (ET) is a monosymptomatic disease with tremor as the only symptom and without an underlying cause in the form of other neurological diagnoses. ET presents most commonly as a postural tremor of the hands, although a head or voice tremor are often seen. […]

Categories: ET Treatment

By Anthony E. Lang, M.D., F.R.C.P.(C) A number of drugs and illnesses are capable of causing tremor in their own right or worsening tremor in predisposed individuals. All of us have fine tremor, known as physiologic tremor that can be documented with sensitive recording devices. There are many factors capable of accentuating physiologic tremor to […]

Posted on August 10, 2021

By Dr. Albert Fenoy,Director, Deep Brain Stimulation ProgramAssociate Professor, Department of NeurosurgeryMcGovern Medical SchoolThe University of Texas at Houston Patients with essential tremor (ET) usually present with hand tremor, an involuntary shaking of the hands dependent on position. However, head tremor can also develop in the course of ET or present as a singular symptom. […]

Posted on June 28, 2021

Information courtesy of the Medicare Plans Resource Center Many of us find signing up for health insurance to be needlessly complicated, confusing, and stressful. Unfortunately, when it comes to signing up for Medicare while considering a specific healthcare issue such as essential tremor (ET), things aren’t much simpler. Medicare is a health insurance program provided […]

Categories: ET Treatment, Support
Posted on June 17, 2021

This official IETF Essential Tremor in Adult Patients Guidelines Advisory provides clinicians with instant access to current best practices in a clear concise format. It was developed in collaboration with Guideline Central and the IETF, and authored by: Kelly Lyons, PhD Kelli Reiling Ott, OTD, OTR/L Holly Shill, MD What’s Inside? Overview/Background/Prevalence Assessment/Screening Differential Diagnosis […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for major depressive disorder (MDD), postpartum depression (PPD) and other psychiatric disorders and SAGE-324 for essential tremor and other neurological disorders.

Posted on July 23, 2020

Clinical trials can be confusing. Amber Trzeciak, with Cadent Therapeutics, explains how they work and why they are important for the development of new drugs and treatments for medical conditions like essential tremor.

Posted on March 5, 2020

Steadiwear has a personal interest in raising the curtain on essential tremor and helping those who have it live a better life. While studying structural engineering at the University of Toronto, co-founder and CEO of Steadiwear Mark Elias visited his family over the winter holidays. As he was having coffee with his grandmother and discussing […]

If you are considering surgery as a treatment option for your essential tremor, there are some things you will want to consider before scheduling your surgical appointment. It is vital you fully understand the possible risks and benefits of the procedure. False expectations and inaccurate information can lead to negative outcomes, so it is best […]

By Jean P. Hubble, MD The diagnosis is usually quite obvious – rhythmic shaking of the hands. Despite the fact that essential tremor (ET) is common and easily recognized, there are many aspects about the clinical presentation which are poorly understood. Virtually all individuals with ET have tremor of the hands. The next most frequently […]